Search details
1.
Consensus classification of pediatric hepatocellular tumors: A report from the Children's Hepatic tumors International Collaboration (CHIC).
Pediatr Blood Cancer
; : e30505, 2023 Jun 29.
Article
in English
| MEDLINE | ID: mdl-37384428
2.
Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
Nature
; 526(7575): 700-4, 2015 Oct 29.
Article
in English
| MEDLINE | ID: mdl-26466568
3.
Undifferentiated sarcoma of the liver: Multicenter international experience of the Cooperative Soft-Tissue Sarcoma Group and Polish Paediatric Solid Tumor Group.
Pediatr Blood Cancer
; 67(11): e28598, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32706511
4.
Treatment and outcome of the patients with rhabdomyosarcoma of the biliary tree: Experience of the Cooperative Weichteilsarkom Studiengruppe (CWS).
BMC Cancer
; 19(1): 945, 2019 Oct 14.
Article
in English
| MEDLINE | ID: mdl-31610788
5.
IL-6 trans-signaling is essential for the development of hepatocellular carcinoma in mice.
Hepatology
; 65(1): 89-103, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27770462
6.
ETV6-NTRK3 in congenital mesoblastic nephroma: A report of the SIOP/GPOH nephroblastoma study.
Pediatr Blood Cancer
; 65(4)2018 Apr.
Article
in English
| MEDLINE | ID: mdl-29286563
7.
High-dose treatment for malignant rhabdoid tumor of the kidney: No evidence for improved survival-The Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) experience.
Pediatr Blood Cancer
; 65(1)2018 Jan.
Article
in English
| MEDLINE | ID: mdl-28843054
8.
Systemic therapy of aggressive fibromatosis in children and adolescents: Report of the Cooperative Weichteilsarkom Studiengruppe (CWS).
Pediatr Blood Cancer
; 65(5): e26943, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29316163
9.
Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
Lancet Oncol
; 18(1): 122-131, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27884679
10.
Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.
Am J Med Genet A
; 173(4): 1017-1037, 2017 Apr.
Article
in English
| MEDLINE | ID: mdl-28168833
11.
The impact of local control in the treatment of type II/III pleuropulmonary blastoma. Experience of the Cooperative Weichteilsarkom Studiengruppe (CWS).
J Surg Oncol
; 115(2): 164-172, 2017 Feb.
Article
in English
| MEDLINE | ID: mdl-28103635
12.
The prognostic impact of SYT-SSX fusion type and histological grade in pediatric patients with synovial sarcoma treated according to the CWS (Cooperative Weichteilsarkom Studie) trials.
Pediatr Blood Cancer
; 64(1): 89-95, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27621063
13.
Mutually exclusive BCOR internal tandem duplications and YWHAE-NUTM2 fusions in clear cell sarcoma of kidney: not the full story.
J Pathol
; 238(5): 617-20, 2016 Apr.
Article
in English
| MEDLINE | ID: mdl-27000436
14.
2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic Tumors.
Klin Padiatr
; 229(3): 147-167, 2017 May.
Article
in English
| MEDLINE | ID: mdl-28561228
15.
Pediatric NUT-midline carcinoma: Therapeutic success employing a sarcoma based multimodal approach.
Pediatr Hematol Oncol
; 34(4): 231-237, 2017 May.
Article
in English
| MEDLINE | ID: mdl-29040054
16.
Small cell undifferentiated (SCUD) hepatoblastomas: All malignant rhabdoid tumors?
Genes Chromosomes Cancer
; 55(12): 925-931, 2016 12.
Article
in English
| MEDLINE | ID: mdl-27356182
17.
The clinical phenotype of YWHAE-NUTM2B/E positive pediatric clear cell sarcoma of the kidney.
Genes Chromosomes Cancer
; 55(2): 143-7, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26542179
18.
Outcome, Treatment, and Treatment Failures in Patients Suffering Localized Embryonal Paratesticular Rhabdomyosarcoma: Results From the "Cooperative Weichteilsarkom Studiengruppe" Trials CWS-86, -91, -96, and -2002P.
Ann Surg
; 264(6): 1148-1155, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27828824
19.
Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.
Lancet
; 386(9999): 1156-64, 2015 Sep 19.
Article
in English
| MEDLINE | ID: mdl-26164096
20.
Improvements in the Treatment of Patients Suffering from Bladder-Prostate Rhabdomyosarcoma: A Report from the CWS-2002P Trial.
Ann Surg Oncol
; 23(12): 4067-4072, 2016 11.
Article
in English
| MEDLINE | ID: mdl-27387676